Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 임경민 | * |
| dc.date.accessioned | 2025-11-04T16:30:03Z | - |
| dc.date.available | 2025-11-04T16:30:03Z | - |
| dc.date.issued | 2025 | * |
| dc.identifier.issn | 2079-9284 | * |
| dc.identifier.other | OAK-38189 | * |
| dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/273267 | - |
| dc.description.abstract | Althaea rosea flower extract (ARFE) is widely used as a food and cosmetic ingredient. However, the systemic safety of ARFE for use in cosmetics has not been confirmed, yet. Here, we adopted the threshold of toxicological concern (TTC) and history of safe food consumption approaches to evaluate the systemic safety of ARFE as a cosmetic ingredient. A systematic literature review identified 48 chemical constituents in ARFE, 92.6% of which are common food components. Through a literature review, 48 chemical constituents of ARFE were identified. To exclude the potential genotoxicity issues, in silico predictions of an in vitro AMES test and additional literature reviews were performed, demonstrating that all the chemical constituents of ARFE have no genotoxicity issues. To evaluate the systemic toxicity of ARFE, a comparison with the dietary intake of ARFE was performed. The daily dietary intake of ARFE through tea products was estimated to be 66.67 mg/kg/day. Since exposure to ARFE through cosmetic use ranges from 0.0045 to 5.380 mg/kg/day, which is far lower than dietary intake, it is unlikely to pose any additional health risk. The TTC approach along with in silico predictions of dermal absorption also revealed that systemic exposure doses (SEDs) of all the chemical constituents are below TTC thresholds, further supporting its systemic safety for use in cosmetics. © 2025 Elsevier B.V., All rights reserved. | * |
| dc.language | English | * |
| dc.publisher | Multidisciplinary Digital Publishing Institute (MDPI) | * |
| dc.subject | Althaea Rosea Flower Extract | * |
| dc.subject | Cosmetics | * |
| dc.subject | Hollyhock | * |
| dc.subject | Next-generation Risk Assessment (ngra) | * |
| dc.subject | Safety Assessment | * |
| dc.subject | Threshold Of Toxicological Concern Approach (ttc) | * |
| dc.subject | Apigenin | * |
| dc.subject | Caffeic Acid | * |
| dc.subject | Chlorogenic Acid | * |
| dc.subject | Coumaric Acid | * |
| dc.subject | Ferulic Acid | * |
| dc.subject | Gallic Acid | * |
| dc.subject | Hydrocinnamic Acid | * |
| dc.subject | Luteolin | * |
| dc.subject | Malvidin Chloride | * |
| dc.subject | Naringenin | * |
| dc.subject | Pelargonidin | * |
| dc.subject | Protocatechuic Acid | * |
| dc.subject | Quercetin | * |
| dc.subject | Rutoside | * |
| dc.subject | Syringic Acid | * |
| dc.subject | Chemtunes | * |
| dc.subject | Episuite | * |
| dc.subject | Toxtree Package 3.1 | * |
| dc.subject | Anthocyanin | * |
| dc.subject | Cosmetic | * |
| dc.subject | Cyanidin | * |
| dc.subject | Flavonoid | * |
| dc.subject | Flower Extract | * |
| dc.subject | Gallocatechin Gallate | * |
| dc.subject | Kaempherol | * |
| dc.subject | Petunidin | * |
| dc.subject | Unclassified Drug | * |
| dc.subject | Article | * |
| dc.subject | Boiling Point | * |
| dc.subject | Chemical Analysis | * |
| dc.subject | Computer Model | * |
| dc.subject | Dietary Intake | * |
| dc.subject | Drug Safety | * |
| dc.subject | Drug Use | * |
| dc.subject | Flower | * |
| dc.subject | Food Intake | * |
| dc.subject | Genotoxicity | * |
| dc.subject | Health Hazard | * |
| dc.subject | Hematological Parameters | * |
| dc.subject | Human | * |
| dc.subject | Limit Of Detection | * |
| dc.subject | Limit Of Quantitation | * |
| dc.subject | Mean Corpuscular Hemoglobin | * |
| dc.subject | Melting Point | * |
| dc.subject | Nonhuman | * |
| dc.subject | Physical Chemistry | * |
| dc.subject | Risk Assessment | * |
| dc.subject | Skin Absorption | * |
| dc.subject | Systematic Review | * |
| dc.subject | Tea | * |
| dc.subject | Toxicology | * |
| dc.subject | Vapor Pressure | * |
| dc.title | Assessment of Systemic Safety of Althaea rosea Flower Extract for Use in Cosmetics: Threshold of Toxicological Concern and History of Safe Consumption Approaches | * |
| dc.type | Article | * |
| dc.relation.issue | 4 | * |
| dc.relation.volume | 12 | * |
| dc.relation.index | SCOPUS | * |
| dc.relation.journaltitle | Cosmetics | * |
| dc.identifier.doi | 10.3390/cosmetics12040133 | * |
| dc.identifier.scopusid | 2-s2.0-105014507338 | * |
| dc.author.google | Gil S. | * |
| dc.author.google | Lim K. | * |
| dc.contributor.scopusid | 임경민(8916551700) | * |
| dc.date.modifydate | 20260702143034 | * |